Newer approaches to androgen deprivation therapy in prostate cancer

By Pitts W.R.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 882-882

Elsevier

Access to resources Recommend Favorite

Timing of androgen deprivation for prostate cancer: benefits versus side effects-a patient-physician dialogue

By Soloway M.S.  

Urology, Vol. 60, Iss. 5, 2002-11 ,pp. : 735-737

Elsevier

Access to resources Recommend Favorite

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

By Wright G.L.   Grob M.   Haley C.   Grossman K.   Newhall K.   Petrylak D.   Troyer J.   Konchuba A.   Schellhammer P.F.   Moriarty R.  

Urology, Vol. 48, Iss. 2, 1996-08 ,pp. : 326-334

Elsevier

Access to resources Recommend Favorite

Androgen deprivation therapy for prostate cancer results in significant loss of bone density

By Wei J.T.   Gross M.   Jaffe C.A.   Gravlin K.   Lahaie M.   Faerber G.J.   Cooney K.A.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 607-611

Elsevier

Access to resources Recommend Favorite

The Impact of Prostate Volume Following Neoadjuvant Androgen Deprivation on Quality of Life and Voiding Symptoms in Patients Undergoing Permanent Prostate Brachytherapy

By Krupski T.   Bissonette E.A.   Petroni G.R.   Theodorescu D.  

European Urology, Vol. 43, Iss. 5, 2003-05 ,pp. : 467-472

Elsevier

Access to resources Recommend Favorite